CAROLYN LYN: Open Payments
NPI 1093872988 · HUNTINGTON BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$721 in 31 payments from 17 companies in 2025. Trend: 2023 $766 · 2024 $630 · 2025 $721
Food & beverage: $721
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $92 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $88 |
| Amgen Inc. | 3 | $71 |
| Novo Nordisk Inc | 3 | $66 |
| Corcept Therapeutics | 2 | $54 |
| Radius Health, Inc. | 2 | $52 |
| Novartis Pharmaceuticals Corporation | 2 | $45 |
| PFIZER INC. | 2 | $34 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $32 |
| ABBVIE INC. | 1 | $30 |
Products named: AIRSUPRA, CAPLYTA, Korlym, OTEZLA, Tymlos, LEQVIO, Ozempic, NURTEC ODT.
Industry payments across CA — which companies pay providers there.
